Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Dittert

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Deutsches Arzteblatt International|April 12, 2022
Unusual Differential Diagnosis in Suspected MeningitisPhilipp Dittert, Kay Geert Hermann, Gerd Rüdiger Burmester
EULAR Rheumatology Open|June 29, 2026
Systemic sclerosis triggered by bleomycin: a 5-year follow-upPhilipp Dittert, Martin Krusche, Lennard Ostendorf, et al.
Rheumatology (Oxford, England)|September 21, 2022
Eosinophilic fasciitis (Shulman syndrome)-recognition of the histological spectrum allows for new insights into possible pathomechanismsDebora Pehl, Corinna Preuße, Yves Allenbach, et al.
Scientific Reports|May 14, 2021
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patientsLennard Ostendorf, Philipp Dittert, Robert Biesen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Deutsches Arzteblatt International|April 12, 2022
Unusual Differential Diagnosis in Suspected MeningitisPhilipp Dittert, Kay Geert Hermann, Gerd Rüdiger Burmester
EULAR Rheumatology Open|June 29, 2026
Systemic sclerosis triggered by bleomycin: a 5-year follow-upPhilipp Dittert, Martin Krusche, Lennard Ostendorf, et al.
Rheumatology (Oxford, England)|September 21, 2022
Eosinophilic fasciitis (Shulman syndrome)-recognition of the histological spectrum allows for new insights into possible pathomechanismsDebora Pehl, Corinna Preuße, Yves Allenbach, et al.
Scientific Reports|May 14, 2021
SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patientsLennard Ostendorf, Philipp Dittert, Robert Biesen, et al.
Pageof 1